Literature DB >> 15555651

Predicting individual outcomes in hepatocellular carcinoma.

Norio Iizuka1, Yoshihiko Hamamoto, Masaaki Oka.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15555651     DOI： 10.1016/S0140-6736(04)17455-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy.

Authors:  Yukio Tokumitsu; Kazuhiko Sakamoto; Yoshihiro Tokuhisa; Hiroto Matsui; Satoshi Matsukuma; Yoshinari Maeda; Koichiro Sakata; Hiroshi Wada; Hidetoshi Eguchi; Hiroyuki Ogihara; Yusuke Fujita; Yoshihiko Hamamoto; Norio Iizuka; Tomio Ueno; Hiroaki Nagano
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

Review 2.  Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma.

Authors:  Tohru Utsunomiya; Mitsuo Shimada; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Masaki Mori
Journal:  J Gastroenterol       Date:  2009-12-08       Impact factor: 7.527

3.  Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus.

Authors:  Norio Iizuka; Ryouichi Tsunedomi; Takao Tamesa; Toshimasa Okada; Kazuhiko Sakamoto; Takashi Hamaguchi; Hisafumi Yamada-Okabe; Takanobu Miyamoto; Shunji Uchimura; Yoshihiko Hamamoto; Masaaki Oka
Journal:  J Cancer Res Clin Oncol       Date:  2006-04-25       Impact factor: 4.553

4.  Identifying genes progressively silenced in preneoplastic and neoplastic liver tissues.

Authors:  Kellie J Archer; Zhongming Zhao; Tobias Guennel; Daniel G Maluf; Robert A Fisher; Valeria R Mas
Journal:  Int J Comput Biol Drug Des       Date:  2010-08-05

5.  Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers.

Authors:  Myron Schwartz; Igor Dvorchik; Sasan Roayaie; M Isabel Fiel; Sidney Finkelstein; J Wallis Marsh; John A Martignetti; Josep M Llovet
Journal:  J Hepatol       Date:  2008-05-20       Impact factor: 25.083

6.  High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.

Authors:  Kellie J Archer; Valeria R Mas; Daniel G Maluf; Robert A Fisher
Journal:  Mol Genet Genomics       Date:  2010-02-18       Impact factor: 3.291

7.  MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria.

Authors:  Fumiaki Sato; Etsuro Hatano; Koji Kitamura; Akira Myomoto; Takeshi Fujiwara; Satoko Takizawa; Soken Tsuchiya; Gozoh Tsujimoto; Shinji Uemoto; Kazuharu Shimizu
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

8.  Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes.

Authors:  Katherine S Koch; Hyam L Leffert
Journal:  Hepat Med       Date:  2010-03

9.  An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.

Authors:  Yukio Tokumitsu; Takao Tamesa; Satoshi Matsukuma; Noriaki Hashimoto; Yoshinari Maeda; Yoshihiro Tokuhisa; Kazuhiko Sakamoto; Tomio Ueno; Shoichi Hazama; Hiroyuki Ogihara; Yusuke Fujita; Yoshihiko Hamamoto; Masaaki Oka; Norio Iizuka
Journal:  Int J Oncol       Date:  2014-12-17       Impact factor: 5.650

10.  Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma.

Authors:  Y Tokuhisa; N Iizuka; I Sakaida; T Moribe; N Fujita; T Miura; S Tamatsukuri; H Ishitsuka; K Uchida; S Terai; K Sakamoto; T Tamesa; M Oka
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.